Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-05-31Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia.Unknown journal · 2026-04-23A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-03-12Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in ratsResearch Square · 2026-02-22Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortexbioRxiv · 2025-12-25Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injuryMolecular Psychiatry · 2025-11-04Psychedelics Relax Priors and Reshape Orbitofrontal DynamicsbioRxiv · 2025-09-18Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesiabioRxiv · 2025-09-16Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.Unknown journal · 2025-07-13Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?Unknown journal · 2025-05-18A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Among Psychedelics, Only Psilocybin Has Demonstrated Benefit to Treat Depression.PubMed · 2025-01-31Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates the gabapentin-mediated analgesiaResearch Square · 2024-09-19Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectanciesPsyArXiv · 2024-06-09Do undergraduates’ views of psychedelics relate to the context for psychedelic use?PsyArXiv · 2024-04-23Psilocybin for the Treatment of Obsessive-Compulsive Disorders.Unknown journal · 2021-12-31Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.Cerebral Cortex · 2021-10-31Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case StudiesmedRxiv · 2021-04-06Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive DisorderYearbook of Psychiatry and Applied Mental Health · 2007-12-31Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand.Unknown journal · 1994-06-30Species identification and chemical analysis of psychoactive fungi in the Hawaiian islands.Unknown journal · 1993-08-31Psychoactive mushroom use in Koh Samui and Koh Pha-Ngan, Thailand.Unknown journal · 1991-12-31